Department of Anaesthesiology and Intensive Care Medicine, Hannover Medical School, Carl Neuberg Strasse 1, Hannover, Germany.
Eur J Anaesthesiol. 2012 Apr;29(4):204-7. doi: 10.1097/EJA.0b013e328350677b.
Airway management in children suffering from mucopolysaccharidosis 1 (Hurler syndrome) remains challenging despite advances in both treatment and airway management techniques.
Forty-one anaesthetic charts following ten children over a 6-year period (2004-2010) were reviewed with emphasis on airway problems.
All children had early stem cell transplantation at the age of 2 years or earlier. Mean (SD) age was 5 (4.3) years. Mask ventilation was difficult in five of 41 (12%) anaesthetics or in three of ten children. There were 29 intubations. Direct laryngoscopy was described as difficult (Cormack and Lehane ≥3) on 11 occasions in five of ten children. There were three of 26 (12%) failed intubations with direct laryngoscopy. These situations were resolved by a fibre-optic procedure, by laryngeal mask airway (LMA) insertion or by use of a videolaryngoscope. A laryngeal mask airway was used 11 times to avoid invasive airway management and once when direct laryngoscopy was impossible.
The airway management of children with mucopolysaccharidosis 1 remains critical, despite advances in both treatment and airway management techniques. Problems did not seem to increase as children grew older. We assume that technical improvements such as standardised use of the laryngeal mask airway or attached tube channel videolaryngoscopes as well as a stem cell transplantation treatment of the disease helped the management of older children with mucopolysaccharidosis 1.
尽管在治疗和气道管理技术方面都取得了进步,但患有黏多糖贮积症 1 型(Hurler 综合征)的儿童的气道管理仍然具有挑战性。
回顾了 10 名儿童在 6 年期间(2004-2010 年)的 41 份麻醉图表,重点关注气道问题。
所有儿童均在 2 岁或更早时进行了早期干细胞移植。平均(SD)年龄为 5(4.3)岁。面罩通气在 41 次麻醉中的 5 次(12%)或 10 名儿童中的 3 次困难。有 29 次插管。在 10 名儿童中的 5 名中,有 11 次直接喉镜检查被描述为困难(Cormack 和 Lehane≥3)。直接喉镜检查有 3 次(26%)插管失败。这些情况通过纤维光学程序、喉罩气道(LMA)插入或使用视频喉镜解决。为避免有创气道管理,11 次使用喉罩气道,1 次因直接喉镜检查不可能而使用。
尽管在治疗和气道管理技术方面都取得了进步,但黏多糖贮积症 1 型儿童的气道管理仍然至关重要。随着儿童年龄的增长,问题似乎并没有增加。我们假设,技术改进,如标准化使用喉罩气道或附加管通道视频喉镜,以及干细胞移植治疗该疾病,有助于管理年龄较大的黏多糖贮积症 1 型儿童。